Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

BioBAA

Financiado

Cerrado

Disruptive platform for sustainable and low cost amino acid production

Serine and Cysteine are two commercially important AAs. However, both present severe limitations regarding their production’s environmental and economic sustainability, which limits their market potential and causing a large negat... ver más

31/05/2023

CYSBIO

3M€

Presupuesto del proyecto: 3M€

Líder del proyecto

CYSBIO No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2023-05-31

H2020-EIC-SMEInst-2020-4: H2020-EIC Accelerator pilot –SME In...

I+D

Cerrada hace 4 años

0% 70% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

CYSBIO

2.06M€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

BIOSUSAMIN The design and development of efficient biocatalytic cascade... 1M€ Cerrado

CTQ2015-63563-R DESARROLLO DE BIOCATALIZADORES PARA LA FORMACION DE ENLACES... 100K€ Cerrado

KYROBIO The discovery development and demonstration of biocatalysts... 8M€ Cerrado

EUR2023-143462 Química 100K€ Cerrado

CNS2023-144752 Ingeniería química 193K€ Cerrado

GREASEDLIGHTNING Enzymatic chemistry acting on alkyl chains 2M€ Cerrado

Duración del proyecto: 30 meses Fecha Inicio: 2020-11-12
Fecha Fin: 2023-05-31

Líder del proyecto

CYSBIO No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 3M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Serine and Cysteine are two commercially important AAs. However, both present severe limitations regarding their production’s environmental and economic sustainability, which limits their market potential and causing a large negative environmental impact. Supported by advanced patented-metabolic engineering and synthetic biology approaches Cysbio developed a bio-based platform for AA production - AA-Platform - with an unprecedented environmental and economic performance. Through the design of proprietary cell factories (Escherichia coli), Cysbio was able to combine, balance and tune the different metabolic pathways involved in Ser production. The accomplishment of the AA-platform performance is also due to: i) the sustainable and cost-efficient bioconversion of Ser into Cys; ii) efficient and multi-sourced (i.e. can use sources of glucose, maltose or glycerol with limited impact on process’s efficiency); and iii) sustainable upstream and downstream processes. Building from these strong value propositions, this innovative platform yields a significant advantage against competitors’ products and will radically change the market, by creating the cheapest AAs (Ser<2.1 €/Kg and Cys<2.5€/Kg and longer term the target is >1 €/Kg and >2 €/Kg respectively) and in an environmentally sustainable manner. This will allow companies and society at large to replace fossil-based, energy consuming and polluting processes and products with sustainable, bio-based alternatives. Cysbio is currently a small and agile company, whose business strategy is to move quickly into the market by taking a large share of the existing Ser and Cys market segments and by creating a new one, replacing part of Met added in the chicken feed (with a market size of 5.4€Bn) with our sustainable and inexpensive Cys. The BioBAA project is at the core of this strategy and is what drives the company´s mission and future activities for a successful development.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores